Must-See Charts: How Healthy Are Bristol-Myers, Eli Lilly, Pfizer, Merck?

The healthcare sector has looked unhealthy compared with the broader stock market after the first four months of 2016. The sector is down 3.1% compared with an S&P 500 up just 1%. As 2016 began, TheStreet's Jim Cramer named 38 stocks he thought would perform well in 2016, including pharma giants Bristol-Myers Squibb , Eli Lilly and Dow Jones Industrial Average component Pfizer , which reports quarterly earnings this week. However, Cramer changed his mind about Lilly last month because of disap...